Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Whole exome sequencing suggests much of non BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.

ABSTRACT: Whole exome sequencing identification of putative founder mutations in non-BRCA1/2 breast cancer patients

ORGANISM(S): Homo sapiens

DISEASE(S): normal

SUBMITTER: Javier Gracia 

PROVIDER: E-MTAB-1172 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml

Similar Datasets

Unknown Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.
| S-EPMC3568132 | biostudies-literature
Genomics Whole exome sequencing suggests much of non BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.
| PRJEB3235 | ENA
Unknown Meta-analysis of BRCA1 and BRCA2 penetrance.
| S-EPMC2267287 | biostudies-literature
Unknown A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects.
| S-EPMC4501173 | biostudies-literature
Unknown Molecular classification of familial non-BRCA1/BRCA2 breast cancer.
| S-EPMC151375 | biostudies-literature
Unknown Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
| S-EPMC5824270 | biostudies-literature
Unknown Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients.
| S-EPMC5498630 | biostudies-literature
Unknown Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon.
| S-EPMC3441239 | biostudies-literature
Unknown BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
| S-EPMC4439391 | biostudies-literature
Unknown Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
| S-EPMC3458423 | biostudies-literature